Vimarsana
Biggest News Aggregation in the World

Page 4 - Dole Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dole Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dole Act Today - Breaking & Trending Today

The White House's Latest Move to Rein in Drug Prices - Vimarsana News

The White House's Latest Move to Rein in Drug Prices

Drug companies use tax-payer money to develop drugs and sell them at high prices. The White House says it’s going to make this stop.

Source: yahoo.com
White House announces readiness to deploy 'march-in rights' to target high drug prices - Vimarsana News

White House announces readiness to deploy 'march-in rights' to target high drug prices

The Biden administration is rolling out a framework to enforce the government’s march-in authorities on drugs developed with taxpayer dollars, saying if…

Source: biztoc.com
Related Topics:
Dole ActReaking News
NPA Says House of Representatives' Passage of Bill to Provide Veterans Additional Access to the Program of All-Inclusive Care for the Elderly Will Improve Their Lives; Urges Swift Senate Passage - Vimarsana News

NPA Says House of Representatives' Passage of Bill to Provide Veterans Additional Access to the Program of All-Inclusive Care for the Elderly Will Improve Their Lives; Urges Swift Senate Passage

/PRNewswire/ -- On the second anniversary of the passing of the Honorable Bob Dole (R-KS), the National PACE Association (NPA) praises the U.S. House of...

U.S. House passes three Veterans' bills | American Samoa - Vimarsana News

U.S. House passes three Veterans' bills | American Samoa

Washington, D.C. —  House of Representives passed three bills addressing various Veterans’ issues that originated in the House Veterans’ Affairs Committee.

Leute: March-in rights misuse - Vimarsana News

Leute: March-in rights misuse

The federal government rejected a petition to unilaterally slash the price of the prostate cancer drug Xtandi in a closely watched decision this spring. Making drugs more affordable is undoubtedly